Traditionally, it has been believed that the expression of PD-L1 can be driven by carcinogenic signaling pathways in cancer cells, which can lead to immune escape via innate immune resistance, which is associated with poor prognosis in patients (22, 23, 28, 29). Here, CD274 is linked to cancer.